Gut microbiome emerges as key clue to cancer drug side effects
Researchers at the South Australian Health and Medical Research Institute have identified how the gut microbiome influences side effects of the cancer drug bortezomib. The study links the treatment to nerve-immune signaling changes, offering a potential path to mitigating painful neuropathy and gastrointestinal issues for patients.
Why it matters
Understanding the biological mechanisms behind chemotherapy side effects can significantly improve the quality of life and treatment adherence for cancer patients.
by South Australian Health and Medical Research Institute
The article is a straightforward report on scientific research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in